The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study-Reference-Cited by-同舟云学术

The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study

Published:2020-12 Issue: Volume:4 Page:100097
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Aneni Ehimen C.,Bittencourt Marcio Sommer^ORCID,Teng Catherine,Cainzos-Achirica Miguel,Osondu Chukwuemeka U.,Soliman Ahmed,Al-Mallah Mouaz,Buddoff Matthew,Parise Edison R.,Santos Raul D.,Nasir Khurram

Funder

Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico

Publisher

Elsevier BV

Reference32 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat. Rev. Gastroenterol. Hepatol.,2018

2. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps;Santos;Atherosclerosis,2019

3. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis;Targher;J. Hepatol.,2016

4. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review;Stahl;J. Am. Coll. Cardiol.,2019

5. Nonalcoholic fatty liver disease 2020: the state of the disease;Cotter;Gastroenterology,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis;Current Problems in Cardiology;2024-06

2. Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus;World Journal of Hepatology;2024-03-27

3. What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside;Journal of Clinical Medicine;2024-01-03

4. Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease;Obesity Research & Clinical Practice;2023-09

5. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies;Clinical Gastroenterology and Hepatology;2023-09